SCHEMBL7663306

SCHEMBL7663306

O=Cc1ccoc1S(=O)(=O)O

nearest known ligand 0.37

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.37
MEN1 O00255 1/20 0.33
LMNA P02545 1/20 0.33
THRB P10828 1/20 0.33
BLM P54132 1/20 0.33
KMT2A Q03164 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
ERN1 O75460 4/20 0.33
TRIM24 O15164 1/20 0.32
TRIM33 Q9UPN9 1/20 0.32
HCAR2 Q8TDS4 1/20 0.31
CYP2A6 P11509 1/20 0.31
TSHR P16473 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8051718 0.98 ALDH1A1 (0.35) ALDH1A1MEN1LMNATHRBBLM
SCHEMBL8051720 0.77 PLCG1 (0.36) ALDH1A1MEN1LMNATHRBBLM
SCHEMBL7658831 0.76 L3MBTL1 (0.31)
SCHEMBL27651919 0.73 TTR (0.32) ALDH1A1LMNATSHRSMN1; SMN2
SCHEMBL1133097 0.71 ALDH1A1 (0.38) ALDH1A1MEN1LMNATHRBBLM
SCHEMBL25263495 0.71 KDM4E (0.35) ALDH1A1LMNATHRBTSHRSMN1; SMN2
SCHEMBL29155972 0.71 LMNA (0.34) LMNATSHRSMN1; SMN2
SCHEMBL7668779 0.70
SCHEMBL22612036 0.70
SCHEMBL19138056 0.69 ALDH1A1 (0.44) ALDH1A1MEN1LMNATHRBBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0848613-A1 ANALOGS FOR SPECIFIC OLIGOSACCHARIDE-NEUREGULIN INTERACTIONS AND USES THEREOF CAMBRIDGE NEUROSCIENCE, INC. (US) 1998-06-24 EP claimed
WO-1997009051-A1 ANALOGS FOR SPECIFIC OLIGOSACCHARIDE-NEUREGULIN INTERACTIONS AND USES THEREOF CAMBRIDGE NEUROSCIENCE, INC. (US) 1997-03-13 WO claimed
US-6376540-B1 PREVENT NEURODEGENERATIVE DISEASE CENTAUR PHARMACEUTICALS, INC. 2002-04-23 US disclosed
CN-1271353-A Furan sulfonic acid derivatives and pharmaceutical compositions containing the same CENTAUR PHARMACEUTICALS INC (US) 2000-10-25 CN disclosed
EP-1021430-A1 FURAN NITRONE COMPOUNDS CENTAUR PHARMACEUTICALS, INC. (US) 2000-07-26 EP disclosed
EP-1005463-A1 FURANSULFONIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME CENTAUR PHARMACEUTICALS, INC. (US) 2000-06-07 EP disclosed
US-6051571-A NERVOUS SYSTEM DISORDERS; CARDIOVASCULAR DISORDERS CENTAUR PHARMACEUTICALS, INC. (US) 2000-04-18 US disclosed
US-6040444-A Process for preparing furan nitrone compounds CENTAUR PHARMACEUTICALS, INC. (US) 2000-03-21 US disclosed
US-5994396-A Furansulfonic acid derivatives and pharmaceutical compositions containing the same CENTAUR PHARMACEUTICALS, INC. (US) 1999-11-30 US disclosed
US-5942507-A REAGANTS FOR DETECTION FREE RADICALS CENTAUR PHARMACEUTICALS, INC. (US) 1999-08-24 US disclosed
EP-0487343-B1 Process for preparing a lithographic plate FUJI PHOTO FILM CO LTD (JP) 1999-04-28 EP disclosed
WO-1999009022-A1 FURANSULFONIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME CENTAUR PHARMACEUTICALS, INC. (US) 1999-02-25 WO disclosed
WO-1998003496-A1 FURAN NITRONE COMPOUNDS CENTAUR PHARMACEUTICALS, INC. (US) 1998-01-29 WO disclosed
EP-0487343-A1 Process for preparing a lithographic plate Fuji Photo Film Co., Ltd. (JP) 1992-05-27 EP disclosed